MyAverix Finance MyAverix Finance

US · General

Maze Therapeutics, Inc. Common Stock (MAZE)

Biotechnology

Maze Therapeutics, Inc. Common Stock (MAZE) is listed on US in the General sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for MAZE

P/E ratio
25.00

Maze Therapeutics, Inc. Common Stock (MAZE) — FAQ

What is MAZE's P/E ratio?

The price-to-earnings (P/E) ratio for Maze Therapeutics, Inc. Common Stock (MAZE) is 25.00 (data as of 2026-05-23).

Does Maze Therapeutics, Inc. Common Stock pay a dividend?

Dividend yield is not available in the current snapshot for Maze Therapeutics, Inc. Common Stock (MAZE). Check the MyAverix Finance app for the latest dividend data.

What sector is Maze Therapeutics, Inc. Common Stock in?

Maze Therapeutics, Inc. Common Stock (MAZE) is classified in the General sector (Biotechnology industry).

What exchange is MAZE listed on?

MAZE is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play